Drug · DIN 02297787
ACTONEL
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 5, 2016; first marketed August 13, 2007.
- Drug Identification Number (DIN)
- 02297787
- Company (DIN owner)
- Warner Chilcott Canada CoMarkham, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risedronic acid M05BA07
- Class
- Human
- Record last updated
- June 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE) | 75 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 18, 2010: NOC 11062New Drug Submission (NDS) · Manufacturer name change
- July 17, 2007: NOC 8912Supplement to a New Drug Submission (SNDS) · New dosing recommendation and new strength tablet, 75 mg, on two consecutive days per month
Other DINs named ACTONEL
- DIN 02246896 · Marketed
- DIN 02316838 · Marketed
- DIN 02239146 · Cancelled Post Market
- DIN 02242518 · Cancelled Post Market